Loerchner, H.; Widera, C.; Hou, Y.; Elsaesser, A.; Warnecke, H.; Giannitsis, E.; Hulot, J.-S.; Braun, T.; Wollert, K. C.; Poeling, J.: Reg3 beta is associated with cardiac inflammation and provides prognostic information in patients with acute coronary syndrome. INTERNATIONAL JOURNAL OF CARDIOLOGY 258, pp. 7 - 13 (2018)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).